SULFACARBAMIDE


Synonyms	Euvernil N-sulfanilylcarbamide NSC-78438 Sulfacarbamide Sulfaurea Sulphaurea Uractyl Uramid Urenil Uromide Urosulfan
Status
Molecule Category	Free-form
UNII	W6CD25Z4QR
EPA CompTox	DTXSID1046425

Structure


InChI Key	WVAKABMNNSMCDK-UHFFFAOYSA-N
Smiles	NC(=O)NS(=O)(=O)c1ccc(N)cc1
InChI	InChI=1S/C7H9N3O3S/c8-5-1-3-6(4-2-5)14(12,13)10-7(9)11/h1-4H,8H2,(H3,9,10,11)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C7H9N3O3S
Molecular Weight	215.23
AlogP	-0.37
Hydrogen Bond Acceptor	4.0
Hydrogen Bond Donor	3.0
Number of Rotational Bond	2.0
Polar Surface Area	115.28
Molecular species	ACID
Aromatic Rings	1.0
Heavy Atoms	14.0

Related Entries

Cross References

Resources	Reference
ChEBI	134891
ChEMBL	CHEMBL139877
DrugCentral	2496
FDA SRS	W6CD25Z4QR
PubChem	11033
SureChEMBL	SCHEMBL154846
ZINC	ZINC000000053961

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).